A novel biologically active seleno-organic compound—VI
- 1 July 1986
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 35 (13) , 2115-2118
- https://doi.org/10.1016/0006-2952(86)90578-2
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Selective inhibition of leukotriene B4 formation by Ebselen: A novel approach to antiinflammatory therapyInflammation Research, 1986
- A novel biologically active seleno-organic compound—VBiochemical Pharmacology, 1985
- A novel biologically active selenoorganic compound—IV: Protective glutathione-dependent effect of PZ 51 (Ebselen) against ADP-Fe induced lipid peroxidation in isolated hepatocytesBiochemical Pharmacology, 1985
- Diurnal fluctuation and pharmacological alteration of mouse organ glutathione contentBiochemical Pharmacology, 1985
- Production of peptide leukotrienes in endotoxin shockFEBS Letters, 1985
- A novel biologically active seleno-organic compound—IIIBiochemical Pharmacology, 1984
- A novel biologically active seleno-organic compound—IIBiochemical Pharmacology, 1984
- A novel biologically active seleno-organic compound—1Biochemical Pharmacology, 1984
- Acetaminophen hepatotoxicityGastroenterology, 1980
- Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissuesAnalytical Biochemistry, 1969